Home › Funds › venBio Partners LLC › HRMY

venBio Partners LLC position in HRMY

HARMONY BIOSCIENCES HLDGS IN · Health Care

venBio Partners LLC reported holding 472,194 shares of HRMY (HARMONY BIOSCIENCES HLDGS IN) in its Q2 2026 13F filing — a position valued at US$17.2M, representing 3.31% of its reported portfolio and ranking #6 among its reported holdings. venBio Partners LLC has disclosed HRMY holdings in 12 of the last 12 reported quarters, going back to Q3 2023.

Latest position (Q2 2026)472.19K sh
Reported value held$17.19M
Portfolio Weight3.31%
First reportedQ3 2023
Last changeReduce
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How venBio Partners LLC's HRMY position evolved

venBio Partners LLC first disclosed a stake in HRMY in Q3 2023 at 1,035,396 shares (US$33.9M). The position peaked in Q1 2024 at 1,035,396 shares, worth US$34.8M. Across 12 filings, venBio Partners LLC increased the stake 0 time(s), trimmed it 4 time(s) and left it unchanged 7 time(s). The most recent filing (Q2 2026) shows 472,194 shares valued at US$17.2M — a reduction of -17,000 shares quarter over quarter.. Notable position changes include a 41% trim in Q3 2024 (shares fell 14% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2023 1.04M $33.93M New
Q4 2023 1.04M $33.44M Hold
Q1 2024 1.04M $34.77M Hold
Q2 2024 1.04M $31.24M Hold
Q3 2024 614.59K $24.58M Reduce
Q4 2024 539.19K $18.55M Reduce
Q1 2025 489.19K $16.24M Reduce
Q2 2025 489.19K $15.46M Hold
Q3 2025 489.19K $13.48M Hold
Q4 2025 489.19K $18.31M Hold
Q1 2026 489.19K $13.70M Hold
Q2 2026 472.19K $17.19M Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About HRMY and 13F data

HRMY (HARMONY BIOSCIENCES HLDGS IN) is a Health Care company. 36 other funds we track also report a position in HRMY — the largest reported positions include ARMISTICE CAPITAL, LLC (US$56.9M), Valor Management LLC (US$29.8M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding HRMY

All HRMY fund holders →

FAQ

How long has venBio Partners LLC held HRMY?

venBio Partners LLC has disclosed HRMY holdings in 12 of the last 12 reported quarters, going back to Q3 2023.

What is venBio Partners LLC's current position in HRMY?

As of Q2 2026, venBio Partners LLC holds 472.19K shares of HRMY (HARMONY BIOSCIENCES HLDGS IN), valued at $17.19M, representing 3.31% of its reported portfolio and ranking #6.

Has venBio Partners LLC been buying or selling HRMY?

In the latest 13F filing (Q2 2026), venBio Partners LLC reduced its position in HRMY. The position peaked in Q1 2024 at 1.04M shares.

Which other funds hold HRMY?

Other major institutional holders of HRMY include ARMISTICE CAPITAL, LLC, Valor Management LLC, among 36 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.